Study for patients with chronic kidney disease and have itching associated with this condition
Living with CKD and looking for potential relief from itch?Consider taking part in a study of new investigational study medication. Learn more about the KICK-1 study testing the safety and effectiveness of an investigational oral drug called difelikefalin for those who have chronic kidney disease and have itch associated with this condition.
• Are 18 to 85 years of age
• Have been diagnosed with chronic kidney disease
• Are not currently on dialysis
• Have been experiencing daily or near daily itch for at least 6 months.
**There are other requirements for taking part in this study.**
If you qualify, you may receive at no cost: • Treatment with the investigational oral form of difelikefalin • Close care and follow-up throughout the study Participants will be compensated for taking part in the study
If you’re interested in participating in one of our Research Studies:
ext 2150, 2170 or 2190